NO993774L - Karbapenem-forbindelse, anvendelse herav og intermediær forbindelse herav - Google Patents
Karbapenem-forbindelse, anvendelse herav og intermediær forbindelse heravInfo
- Publication number
- NO993774L NO993774L NO993774A NO993774A NO993774L NO 993774 L NO993774 L NO 993774L NO 993774 A NO993774 A NO 993774A NO 993774 A NO993774 A NO 993774A NO 993774 L NO993774 L NO 993774L
- Authority
- NO
- Norway
- Prior art keywords
- diseases
- infectious diseases
- prophylaxis
- agents
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2567197 | 1997-02-07 | ||
| JP24890397 | 1997-09-12 | ||
| PCT/JP1998/000446 WO1998034936A1 (fr) | 1997-02-07 | 1998-02-02 | Composes de carbapenem, leur utilisation et composes intermediaires de celui-ci |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO993774D0 NO993774D0 (no) | 1999-08-04 |
| NO993774L true NO993774L (no) | 1999-09-30 |
Family
ID=26363329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO993774A NO993774L (no) | 1997-02-07 | 1999-08-04 | Karbapenem-forbindelse, anvendelse herav og intermediær forbindelse herav |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6342494B1 (fr) |
| EP (1) | EP0987267B1 (fr) |
| KR (1) | KR100530478B1 (fr) |
| CN (1) | CN1107067C (fr) |
| AT (1) | ATE239728T1 (fr) |
| AU (1) | AU740327C (fr) |
| BG (1) | BG63974B1 (fr) |
| BR (1) | BR9807187A (fr) |
| CA (1) | CA2280273A1 (fr) |
| CZ (1) | CZ272099A3 (fr) |
| DE (1) | DE69814381T2 (fr) |
| ES (1) | ES2198689T3 (fr) |
| HK (1) | HK1026896A1 (fr) |
| HU (1) | HUP0000952A3 (fr) |
| ID (1) | ID22543A (fr) |
| NO (1) | NO993774L (fr) |
| NZ (1) | NZ337532A (fr) |
| PL (1) | PL335048A1 (fr) |
| RU (1) | RU2178792C2 (fr) |
| SK (1) | SK108099A3 (fr) |
| TR (1) | TR199901887T2 (fr) |
| TW (1) | TW580499B (fr) |
| WO (1) | WO1998034936A1 (fr) |
| YU (1) | YU37299A (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0400444A3 (en) * | 2001-05-21 | 2007-02-28 | Kyoto Pharmaceutical Ind | Carbapenem compound, pharmaceutical compositions containing them and their use |
| WO2003040146A1 (fr) | 2001-11-05 | 2003-05-15 | Sumitomo Pharmaceuticals Co., Ltd. | Nouveaux composes carbapenem |
| CA2519794A1 (fr) * | 2003-04-08 | 2004-10-21 | Sumitomo Pharmaceuticals Co., Ltd. | Nouveaux composes de carbapenem |
| JPWO2006025475A1 (ja) * | 2004-09-03 | 2008-05-08 | 大日本住友製薬株式会社 | 新規なカルバペネム化合物 |
| WO2006103999A1 (fr) * | 2005-03-25 | 2006-10-05 | Dainippon Sumitomo Pharma Co., Ltd. | Nouveau composé carbapenem |
| KR100869165B1 (ko) | 2007-09-13 | 2008-11-19 | 조동옥 | 메로페넴의 개선된 제조방법 |
| CN101868460A (zh) * | 2007-11-23 | 2010-10-20 | 国际药品工业株式会社 | 2-芳基甲基吖丁啶-碳青霉烯-3-羧酸酯衍生物或其盐、其制备方法以及包含上述的药物组合物 |
| CN103504481A (zh) * | 2013-10-11 | 2014-01-15 | 红塔烟草(集团)有限责任公司 | 一种带抗菌层烟嘴的电子卷烟 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1283906C (fr) * | 1983-05-09 | 1991-05-07 | Makoto Sunagawa | COMPOSE DE .beta.-LACTAM ET PROCEDE DE PRODUCTION |
| FI81576C (fi) * | 1984-12-25 | 1990-11-12 | Sankyo Co | Foerfarande foer framstaellning av derivat av 6-(1-hydroxietyl)-2-(1,2-disubstituerade-4-pyrrolidinyltio)-2- karbapenem-3-karboxylsyra, vilka aer anvaendbara som laekemedel. |
| IE60588B1 (en) * | 1986-07-30 | 1994-07-27 | Sumitomo Pharma | Carbapenem compound in crystalline form, and its production and use |
| AU644008B2 (en) * | 1990-08-10 | 1993-12-02 | Sumitomo Pharmaceuticals Company, Limited | Beta-lactam compounds, and their production and use |
| US5712267A (en) * | 1991-06-04 | 1998-01-27 | Sankyo Company,. Limited | Carbapenem derivatives, their preparation and their use as antibiotics |
| US5360798A (en) * | 1991-07-04 | 1994-11-01 | Shionogi Seiyaku Kabushiki Kaisha | Aminooxypyrrolidinylthiocarbapenem compounds |
| CZ298246B6 (cs) | 1995-12-21 | 2007-08-01 | Sankyo Company Limited | Deriváty 1-methylkarbapenu, zpusob jejich prípravy a farmaceutické prostredky, které je obsahují |
| JP3671529B2 (ja) | 1996-07-29 | 2005-07-13 | ソニー株式会社 | 熱転写形記録装置及び記録方法 |
-
1998
- 1998-02-02 HU HU0000952A patent/HUP0000952A3/hu unknown
- 1998-02-02 CA CA002280273A patent/CA2280273A1/fr not_active Abandoned
- 1998-02-02 BR BR9807187-4A patent/BR9807187A/pt not_active IP Right Cessation
- 1998-02-02 TR TR1999/01887T patent/TR199901887T2/xx unknown
- 1998-02-02 EP EP98901108A patent/EP0987267B1/fr not_active Expired - Lifetime
- 1998-02-02 KR KR10-1999-7007072A patent/KR100530478B1/ko not_active IP Right Cessation
- 1998-02-02 NZ NZ337532A patent/NZ337532A/en unknown
- 1998-02-02 ES ES98901108T patent/ES2198689T3/es not_active Expired - Lifetime
- 1998-02-02 CZ CZ992720A patent/CZ272099A3/cs unknown
- 1998-02-02 PL PL98335048A patent/PL335048A1/xx not_active Application Discontinuation
- 1998-02-02 DE DE69814381T patent/DE69814381T2/de not_active Expired - Fee Related
- 1998-02-02 WO PCT/JP1998/000446 patent/WO1998034936A1/fr not_active Application Discontinuation
- 1998-02-02 ID IDW990915A patent/ID22543A/id unknown
- 1998-02-02 SK SK1080-99A patent/SK108099A3/sk unknown
- 1998-02-02 RU RU99119323/04A patent/RU2178792C2/ru not_active IP Right Cessation
- 1998-02-02 YU YU37299A patent/YU37299A/sh unknown
- 1998-02-02 CN CN98803928A patent/CN1107067C/zh not_active Expired - Fee Related
- 1998-02-02 AU AU56806/98A patent/AU740327C/en not_active Ceased
- 1998-02-02 AT AT98901108T patent/ATE239728T1/de not_active IP Right Cessation
- 1998-02-02 US US09/355,757 patent/US6342494B1/en not_active Expired - Fee Related
- 1998-02-06 TW TW087101452A patent/TW580499B/zh not_active IP Right Cessation
-
1999
- 1999-08-04 NO NO993774A patent/NO993774L/no not_active Application Discontinuation
- 1999-08-30 BG BG103699A patent/BG63974B1/bg unknown
-
2000
- 2000-09-22 HK HK00106013A patent/HK1026896A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU5680698A (en) | 1998-08-26 |
| ID22543A (id) | 1999-11-04 |
| AU740327B2 (en) | 2001-11-01 |
| DE69814381D1 (de) | 2003-06-12 |
| NZ337532A (en) | 2001-06-29 |
| US6342494B1 (en) | 2002-01-29 |
| KR100530478B1 (ko) | 2005-11-23 |
| CA2280273A1 (fr) | 1998-08-13 |
| AU740327C (en) | 2002-05-09 |
| KR20000070809A (ko) | 2000-11-25 |
| RU2178792C2 (ru) | 2002-01-27 |
| YU37299A (sh) | 2002-06-19 |
| ATE239728T1 (de) | 2003-05-15 |
| EP0987267B1 (fr) | 2003-05-07 |
| CN1107067C (zh) | 2003-04-30 |
| CZ272099A3 (cs) | 1999-11-17 |
| BG63974B1 (bg) | 2003-08-29 |
| BR9807187A (pt) | 2000-01-25 |
| SK108099A3 (en) | 2000-03-13 |
| NO993774D0 (no) | 1999-08-04 |
| HUP0000952A2 (hu) | 2000-10-28 |
| HK1026896A1 (en) | 2000-12-29 |
| EP0987267A1 (fr) | 2000-03-22 |
| CN1252072A (zh) | 2000-05-03 |
| WO1998034936A1 (fr) | 1998-08-13 |
| DE69814381T2 (de) | 2003-12-04 |
| BG103699A (en) | 2000-06-30 |
| TW580499B (en) | 2004-03-21 |
| EP0987267A4 (fr) | 2000-05-31 |
| PL335048A1 (en) | 2000-03-27 |
| TR199901887T2 (xx) | 1999-12-21 |
| ES2198689T3 (es) | 2004-02-01 |
| HUP0000952A3 (en) | 2000-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE247972T1 (de) | Pulmonare abgabe von protonierter/angesäuerter nukleinsäure | |
| PT1235826E (pt) | Acrilamidas de quinuclidina | |
| ATE319710T1 (de) | Antimikrobielle chinolonderivate und ihre verwendung zur behandlung bakterieller infektionen | |
| NO20042271L (no) | Formuleringer som inneholder en cefalosporinforbindelse og deres anvendelse for behandling av bakterielle infeksjoner i katter og hunder | |
| ATE261722T1 (de) | Verwendung von chemotherapeutika zur topischen behandlung | |
| ATE496048T1 (de) | Phenylcarboxamidverbindungen zur schmerzbehandlung | |
| TR200001330T2 (tr) | Oksazolidinon türevleri ve farmasötik terkipler | |
| RU94008616A (ru) | 2-тиозамещенные карбапенемы, промежуточные соединения для получения, способы получения, фармацевтическая композиция, способ лечения бактериальных инфекций | |
| NO993774L (no) | Karbapenem-forbindelse, anvendelse herav og intermediær forbindelse herav | |
| DE60035429D1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
| BR9910098A (pt) | Derivados de carbapenem, utilização dos mesmos e compostos intermediários dos mesmos | |
| CA2386685A1 (fr) | Utilisation de derives de pleuromutiline pour le traitement transdermique de maladies bacteriennes | |
| BR9915639A (pt) | Uso de derivados de ácido fosfonofórmico para o tratamento de infecções | |
| ES2113391T3 (es) | Factor c2a de antibiotico ge 2270. | |
| HUP0003845A2 (hu) | Antimikrobiális 8a-azalidok alkalmazása | |
| TH36001A (th) | สารประกอบคาร์บาเพเนม การใช้ประโยชน์ของมัน และสารประกอบมัธยันตร์ของมัน | |
| DK1196439T3 (da) | Forbindelser udvisende en antibiotikaaktivitet | |
| BR0215070A (pt) | Métodos de tratamento de infecções bacterianas em cães e gatos | |
| CA3242451A1 (fr) | Composition pharmaceutique injectable pour le traitement de maladies respiratoires chez des animaux | |
| NO20013464L (no) | Anvendelse av 3-isoksazolidinoner og hydroksylaminsyrer for behandling av infeksjoner | |
| UA37648A (uk) | Спосіб лікування респіраторних захворювань у телят |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |